ES2541590T3 - Método para la preparación de éster (R)-1-aril-2-tetrazolil-etílico de ácido carbámico - Google Patents

Método para la preparación de éster (R)-1-aril-2-tetrazolil-etílico de ácido carbámico Download PDF

Info

Publication number
ES2541590T3
ES2541590T3 ES09846577.6T ES09846577T ES2541590T3 ES 2541590 T3 ES2541590 T3 ES 2541590T3 ES 09846577 T ES09846577 T ES 09846577T ES 2541590 T3 ES2541590 T3 ES 2541590T3
Authority
ES
Spain
Prior art keywords
alcohol
chemical formula
aryl
asymmetric
represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09846577.6T
Other languages
English (en)
Inventor
Sang Chul Lim
Moo Yong Uhm
Nahm Ryune Cho
Dae Won Lee
Ju Young Lee
Hui Ho Kim
Dong Ho Lee
Hyun Seok Lee
Se Ii Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SK Biopharmaceuticals Co Ltd
Original Assignee
SK Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SK Biopharmaceuticals Co Ltd filed Critical SK Biopharmaceuticals Co Ltd
Application granted granted Critical
Publication of ES2541590T3 publication Critical patent/ES2541590T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Un método para preparar éster 1-aril-2-tetrazolil etílico de ácido carbámico, representado por la Fórmula Química 1, que comprende: someter una arilcetona, representada por la Fórmula Química 2, a reducción asimétrica (R)-selectiva para formar un compuesto de alcohol de configuración (R), representado por la Fórmula Química 5; y carbamar dicho alcohol:**Fórmula** en donde, R1 y R2 son seleccionados independientemente de un grupo que consiste de hidrógeno, halógeno, perfluoroalquilo, un alquilo de 1 a 8 átomos de carbono, un tioalcoxi de 1 a 8 átomos de carbono, y un alcoxi de 1 a 8 átomos de carbono; y uno de A1 y A2 es CH con el otro siendo N; y la reducción (R)-selectiva se consigue por la reducción asimétrica biológica que se lleva a cabo en un tampón que contiene la arilcetona de la Fórmula Química 2, una cepa microbiana capaz de producir oxidorreductasa que se selecciona del grupo que consiste de Candida parapsilosis, Pichia jadinii y Rhodotorula mucilaginosa; y un cosustrato; o la reducción asimétrica química que se consigue con reductor de borano quiral de (-)-Bclorodiisopinocanfeilborano o la hidrogenación por transferencia catalítica asimétrica que se lleva a cabo reaccionando la arilcetona de Fórmula Química 2 con trietilamina de ácido fórmico o base de isopropanolinorgánica en presencia de cloro {[(1S,2S)-(+)-amino-1,2-difeniletil](4-toluenosulfonil)amido}(p-cimeno)rutenio (II).

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
E09846577
03-07-2015
[Tabla 4]
5
15
25
Ejemplo No.
Cepa Producto Tasa [%] de Conversión Pureza Óptica [%]
15
Levadura de Panadería 1N Alcohol 74.6 99.9
16
Saccharomyces cerevisiae KCTC 7108 1N Alcohol 32.7 93.8
17
Saccharomyces cerevisiae KCTC 1205 1N Alcohol 36.6 89.9
18
Saccharomyces cerevisiae KCTC7107 1N Alcohol 18.2 94.6
19
Saccharomyces cerevisiae KCTC 1552 1N Alcohol 19.8 91.8
20
Saccharomyces pastorianus KCTC 1218 1N Alcohol 20.4 92.5
21
Levadura de Panadería 2N Alcohol 85.1 98.1
22
Saccharomyces cerevisiae KCTC 7108 2N Alcohol 57.4 90.5
23
Saccharomyces cerevisiae KCTC 1205 2N Alcohol 64.8 86.5
24
Saccharomyces cerevisiae KCTC7107 2N Alcohol 36 87.7
25
Saccharomyces cerevisiae KCTC 1552 2N Alcohol 38.5 83.3
26
Saccharomyces pastorianus KCTC 1218 2N Alcohol 33.8 77.2
Ejemplos de Preparación 27 a 30: Preparación de 1N Alcohol con Bacterias
Se repitió el mismo procedimiento que en el Ejemplo de Preparación 3, con la excepción de que se usó Klebsiella pneumoniae IFO3319, Bacillus stearothermophilus KCTC1752, Rhodococcus erythropolis KCCM40452 o Rhodococcus rhodochrous ATCC21197 como una cepa productora de oxidorreductasa, en lugar de Rhodotorula mucilaginosa KCTC7117, para proporcionar 1N alcohol de configuración R. Su tasa de conversión y pureza óptica se dan en la Tabla 5, a continuación.
35 Ejemplos de Preparación 31 a 37: Preparación de 2N Alcohol con Bacteria
Se repitió el mismo procedimiento que en el Ejemplo de Preparación 4, con la excepción de que se usó Klebsiella pneumoniae IFO3319, Enterobacter cloacae KCTC2361, Envinia herbicola KCTC2104, Micrococcus luteus KCTC1071, Bacillus stearothermophilus KCTC1752, Rhodococcus erythropolis KCCM40452 o Rhodococcus rhodochrous ATCC21197 como una cepa productora de oxidorreductasa, en lugar de Rhodotorula mucilaginosa KCTC7117, para proporcionar 2N alcohol de configuración R. Su tasa de conversión y pureza óptica se dan en la Tabla 5, a continuación.
[Tabla 5]
45
55
65
Ejemplo No.
Cepa Producto Tasa [%] de Conversión Pureza Óptica [%]
27
Klebsiella pneumonia IFO 3319 1N Alcohol 1.3 99.9
28
Bacillus stearothermophilus KCTC 1752 1N Alcohol 14 94.9
29
Rhodococcus erythropolis KCCM 40452 1N Alcohol 42 90.1
30
Rhodococcus rhodochrous ATCC 21197 1N Alcohol 14.1 92.9
31
Klebsiella pneumonia IFO 3319 2N Alcohol 3.4 99.9
32
Enterobacter cloacae KCTC 2361 2N Alcohol 11.8 89.2
33
Erwinia herbicola KCTC 2104 2N Alcohol 6 87.7
34
Micrococcus luteus KCTC1071 2N Alcohol 13.3 92.6
35
Bacillus stearothermophilus KCTC 1752 2N Alcohol 40.1 88.2
36
Rhodococcus erythropolis KCCM 40452 2N Alcohol 69.8 80.6
37
Rhodococcus rhodochrous ATCC 21197 2N Alcohol 25.4 74.8
13
imagen12
imagen13

Claims (1)

  1. imagen1
    imagen2
    imagen3
ES09846577.6T 2009-06-22 2009-10-14 Método para la preparación de éster (R)-1-aril-2-tetrazolil-etílico de ácido carbámico Active ES2541590T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20090055576 2009-06-22
KR20090055576 2009-06-22
PCT/KR2009/005906 WO2010150946A1 (en) 2009-06-22 2009-10-14 Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester

Publications (1)

Publication Number Publication Date
ES2541590T3 true ES2541590T3 (es) 2015-07-22

Family

ID=43354688

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09846577.6T Active ES2541590T3 (es) 2009-06-22 2009-10-14 Método para la preparación de éster (R)-1-aril-2-tetrazolil-etílico de ácido carbámico

Country Status (17)

Country Link
US (1) US8501436B2 (es)
EP (1) EP2445890B1 (es)
JP (1) JP5683580B2 (es)
KR (1) KR101708433B1 (es)
CN (1) CN102803233B (es)
AU (1) AU2009348523B2 (es)
BR (1) BRPI0924997B1 (es)
CA (1) CA2765566C (es)
CL (1) CL2011003244A1 (es)
ES (1) ES2541590T3 (es)
IL (1) IL216786A (es)
MX (1) MX2011013982A (es)
MY (1) MY155662A (es)
PL (1) PL2445890T3 (es)
RU (1) RU2508290C2 (es)
WO (1) WO2010150946A1 (es)
ZA (1) ZA201109362B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8404461B2 (en) * 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
KR102421006B1 (ko) 2016-05-19 2022-07-14 에스케이바이오팜 주식회사 두통의 예방학적 치료를 위한 카바메이트 화합물의 용도
KR102489052B1 (ko) * 2016-05-19 2023-01-16 에스케이바이오팜 주식회사 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도
KR102421013B1 (ko) * 2016-05-19 2022-07-14 에스케이바이오팜 주식회사 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도
IL267195B2 (en) 2016-12-14 2024-05-01 Sk Biopharmaceuticals Co Ltd Use of carbamate compounds to prevent, alleviate, or treat bipolar disorder
CA3046296A1 (en) 2016-12-14 2018-06-21 Sk Biopharmaceuticals Co., Ltd. Orally disintegrated tablet comprising carbamate compound
MX2019006941A (es) 2016-12-14 2019-09-06 Sk Biopharmaceuticals Co Ltd Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor.
KR102635931B1 (ko) 2016-12-14 2024-02-13 에스케이바이오팜 주식회사 가려움증의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도
WO2018111006A1 (ko) 2016-12-14 2018-06-21 에스케이바이오팜 주식회사 탈수초성 질환의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도
US12070447B2 (en) 2016-12-14 2024-08-27 Sk Biopharmaceuticals Co., Ltd. Parenteral liquid preparation comprising carbamate compound
PL3711758T3 (pl) 2017-11-14 2024-07-01 Sk Biopharmaceuticals Co., Ltd. Zastosowanie związku karbaminianowego do zapobiegania, łagodzenia lub leczenia napadów nieświadomości lub padaczki wykazującej napady nieświadomości
ES2973111T3 (es) 2017-11-14 2024-06-18 Sk Biopharmaceuticals Co Ltd Uso de un compuesto de carbamato para prevenir o tratar enfermedades asociadas con el aumento de la corriente tardía de sodio
AU2018367733B2 (en) 2017-11-14 2024-06-20 Sk Biopharmaceuticals Co., Ltd. Blend containing carbamate compound for prevention, mitigation, or treatment of schizophrenia
US11389429B2 (en) 2017-11-14 2022-07-19 Sk Biopharmaceuticals Co., Ltd. Use of carbamate compound for preventing, alleviating or treating myotonia
WO2019098633A1 (ko) 2017-11-14 2019-05-23 에스케이바이오팜 주식회사 내장통 또는 내장 질환에서 기인한 통증을 예방, 경감 또는 치료하기 위한 카바메이트 화합물의 용도
CA3081224A1 (en) 2017-11-14 2019-05-23 Sk Biopharmaceuticals Co., Ltd. Use of carbamate compound for reducing or treating developmental disorders including fragile x syndrome, angelman syndrome or rett syndrome
CA3112166A1 (en) * 2018-09-21 2020-03-26 Sk Biopharmaceuticals Co., Ltd. Carbamate compound and use of formulation comprising same in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder
CN113242735A (zh) 2018-09-21 2021-08-10 爱思开生物制药株式会社 使用氨基甲酸酯化合物预防、缓解或治疗并发的癫痫发作
KR20210062029A (ko) 2018-10-19 2021-05-28 에스케이바이오팜 주식회사 카바메이트 화합물의 당뇨병성 말초 신경병증 또는 화학요법 유발 말초 신경병증의 예방, 완화 또는 치료를 위한 용도
MX2022004740A (es) * 2019-10-24 2022-05-16 Sk Biopharmaceuticals Co Ltd Metodo para preparar aril 2-tetrazol-2-il cetona con selectividad mejorada.
US10611737B1 (en) * 2019-10-24 2020-04-07 Sk Biopharmaceuticals Co., Ltd. Method for preparing aryl 2-tetrazol-2-yl ketone with improved selectivity
IL293096A (en) 2019-11-22 2022-07-01 Sk Biopharmaceuticals Co Ltd A pharmaceutical preparation for oral administration containing a carbamate compound and a method for its preparation
CN110982757B (zh) * 2019-12-30 2021-04-06 浙江工业大学 阴沟肠杆菌zjph1903及应用
WO2022031099A1 (ko) 2020-08-06 2022-02-10 에스케이바이오팜 주식회사 카바메이트 화합물을 포함하는 경구용 고형 제제 및 이의 제조방법
CN111778198B (zh) * 2020-08-18 2021-12-10 杭州医学院 一种藤黄细球菌hmc01及其在不对称还原制备手性醇中的应用
WO2023152711A1 (en) * 2022-02-12 2023-08-17 Metrochem Api Pvt Ltd Process for the preparation of cenobamate and intermediates thereof
ES2931000B2 (es) * 2022-07-14 2023-07-07 Univ Madrid Complutense Proceso para la preparación de cenobamato

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61134339A (ja) 1984-12-05 1986-06-21 Seitetsu Kagaku Co Ltd α−ジケトンの立体特異的還元による光学活性アルコ−ルならびにその製造方法
JPH054943A (ja) 1990-08-30 1993-01-14 Sagami Chem Res Center 光学活性β，δ−ジケト酸エステル及びその還元体
WO1993004052A1 (en) * 1991-08-22 1993-03-04 Warner-Lambert Company Amide tetrazole acat inhibitors
EP0538693A3 (en) 1991-10-23 1994-08-17 Squibb & Sons Inc Stereoselective preparation of halophenyl alcohols
JP3672307B2 (ja) 1992-03-13 2005-07-20 フォルシュングスツェントルム・ユーリッヒ・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 新規ケトエステル‐還元酵素，その製造方法及びこれを酵素酸化還元反応に使用する方法
WO1994007888A1 (en) 1992-09-25 1994-04-14 Chiroscience Limited Chiral compounds and their use
CA2103932A1 (en) 1992-11-05 1994-05-06 Ramesh N. Patel Stereoselective reduction of ketones
JPH0759592A (ja) 1993-08-25 1995-03-07 Osaka City 光学活性ジオールの製造方法
JP3574682B2 (ja) 1993-09-24 2004-10-06 ダイセル化学工業株式会社 新規な酵素、該酵素を製造する方法、該酵素をコードするｄｎａ、該ｄｎａを含む形質転換体、該酵素による光学活性アルコール等の製造方法
PL177372B1 (pl) 1995-03-30 1999-11-30 Akad Rolnicza Sposób otrzymywaniaoptycznie czynnych alkoholi aromatycznych
DE19610984A1 (de) 1996-03-21 1997-09-25 Boehringer Mannheim Gmbh Alkohol-Dehydrogenase und deren Verwendung zur enzymatischen Herstellung chiraler Hydroxyverbindungen
JPH1094399A (ja) 1996-09-24 1998-04-14 Fukui Pref Gov Sangyo Shinko Zaidan 酵素を用いる光学活性アルコールの製造法
AU4032997A (en) 1997-02-07 1998-08-26 Kaneka Corporation Novel carbonyl reductase, gene that encodes the same, and method of utilizing these
DE19707008A1 (de) 1997-02-21 1998-08-27 Basf Ag Verfahren zur Herstellung von enantiomerenreinen Alkoholen
JPH10248591A (ja) 1997-03-06 1998-09-22 Sumitomo Chem Co Ltd 光学活性アルコールの製造方法
JPH10287634A (ja) 1997-04-11 1998-10-27 Otsuka Pharmaceut Co Ltd ベンゼン誘導体
JPH11130761A (ja) * 1997-10-24 1999-05-18 Otsuka Pharmaceut Co Ltd ベンゾチアゾール誘導体
JP2000236883A (ja) 1998-12-21 2000-09-05 Daicel Chem Ind Ltd 新規なカルボニル還元酵素、該酵素の製造方法、該酵素をコードするｄｎａおよびこれを利用したアルコールの製造方法
KR20010102198A (ko) 1999-02-16 2001-11-15 후루타 타케시 치환 아세틸피리딘 유도체 및 그를 이용하는 광학활성 β3작용제 중간체의 제조 방법
CA2360376C (en) 1999-12-03 2005-04-26 Noriyuki Kizaki Novel carbonyl reductase, gene thereof and method of using the same
DE10037101A1 (de) 2000-07-27 2002-02-07 Degussa Rekombinant hergestellte Enzyme mit verbesserter NAD(H)-Akzeptanz
MXPA03008437A (es) 2001-03-22 2004-01-29 Bristol Myers Squibb Co Reduccion estereoselectiva de acetofenona substituida.
DE10119274A1 (de) 2001-04-20 2002-10-31 Juelich Enzyme Products Gmbh Enzymatisches Verfahren zur enantioselektiven Reduktion von Ketoverbindungen
JP4630486B2 (ja) 2001-05-28 2011-02-09 ダイセル化学工業株式会社 新規な（ｒ）−２，３−ブタンジオール脱水素酵素、その製造方法、及びこれを利用した光学活性アルコールの製造方法
JP2003230398A (ja) 2001-12-07 2003-08-19 Daicel Chem Ind Ltd 光学活性アルコールの製造方法
TW200305645A (en) 2002-03-19 2003-11-01 Mitsubishi Chem Corp Novel carbonyl reductase, gene encoding the same and process for producing optically active alcohols using the same
JP2003289895A (ja) 2002-04-03 2003-10-14 Sumitomo Chem Co Ltd メチレンジオキシフェニル基を有するケトン化合物の不斉還元による光学活性アルコール化合物の製造方法
AU2003235980A1 (en) 2002-04-30 2003-11-17 Kaneka Corporation Novel carbonyl reductase, gene thereof and use of the same
US7056540B2 (en) 2002-10-29 2006-06-06 Council Of Scientific And Industrial Research Enzymatic process for the preparation of optically active alcohols from ketones using tuberous root Daucus carota
JP4366097B2 (ja) 2003-02-28 2009-11-18 住友化学株式会社 還元酵素遺伝子及びその利用
JP4295531B2 (ja) 2003-03-10 2009-07-15 三菱化学株式会社 新規カルボニル還元酵素及びこれをコードするｄｎａ、ならびにこれらを利用した光学活性アルコールの製造方法
DE10315760A1 (de) 2003-04-07 2004-10-21 Basf Ag L-Carnitin Dehydrogenasen, deren Derivate und ein Verfahren zur Herstellung von substituierten (S)-Alkanolen
JP2004313033A (ja) 2003-04-14 2004-11-11 Daiichi Fine Chemical Co Ltd 新規なカルボニル還元酵素及びそれをコードする遺伝子並びにその用途
JP4213524B2 (ja) 2003-04-17 2009-01-21 ダイセル化学工業株式会社 新規なカルボニル還元酵素、その酵素をコードするｄｎａを含むポリヌクレオチド、その製造方法、およびこれを利用した光学活性アルコールの製造方法
JP4294382B2 (ja) 2003-06-06 2009-07-08 ダイセル化学工業株式会社 （２ｓ，３ｓ）−２，３−ブタンジオール脱水素酵素
DE10327454A1 (de) 2003-06-18 2005-01-20 Juelich Enzyme Products Gmbh Oxidoreduktase aus Pichia capsulata
JP4205496B2 (ja) 2003-06-19 2009-01-07 三菱化学株式会社 新規カルボニル還元酵素及びこれをコードするｄｎａ、ならびにこれらを利用した光学活性アルコールの製造方法
DE102004037669A1 (de) 2003-08-13 2005-03-10 Juelich Enzyme Products Gmbh (R)- und (S)-1,4-Dichlor-butan-2-ol und Verfahren zu deren Herstellung durch enantioselektive enzymatische Reduktion von 1,4-Dichlor-butan-2-on
SG128683A1 (en) 2003-10-31 2007-01-30 Daiichi Fine Chem Co Ltd Novel plasmids and utilization thereof
DE10354779A1 (de) 2003-11-21 2005-06-23 Juelich Enzyme Products Gmbh Oxidoreduktase aus Metschnikowia zobellii
EP1712630A4 (en) 2004-02-04 2008-04-16 Api Corp PROCESS FOR THE PRODUCTION OF OPTICALLY ACTIVE ALCOHOL AND OPTICALLY ACTIVE CARBOXYLIC ACID
JP2005218348A (ja) 2004-02-05 2005-08-18 Daicel Chem Ind Ltd 光学活性α−ヒドロキシアミドの製造方法
DE102004022686A1 (de) 2004-05-05 2005-11-24 Basf Ag Verfahren zur Herstellung optisch aktiver Alkohole
AT413541B (de) 2004-05-10 2006-03-15 Iep Gmbh Verfahren zur herstellung von 2-butanol
JP2007274901A (ja) 2004-05-12 2007-10-25 Taisho Pharmaceut Co Ltd 光学活性プロパルギルアルコールの製造方法
DE102004029112B4 (de) 2004-06-11 2007-06-21 Julich Chiral Solutions Gmbh Alkoholdehydrogenase zur stereoselektiven Gewinnung von Hydroxyverbindungen
WO2006046455A1 (ja) 2004-10-27 2006-05-04 Kaneka Corporation 新規カルボニル還元酵素、その遺伝子、およびその利用法
AT501928B1 (de) 2004-10-27 2010-09-15 Iep Gmbh Verfahren zur herstellung von chiralen alkoholen
DE102004059376A1 (de) 2004-12-09 2006-06-22 Consortium für elektrochemische Industrie GmbH GDH-Mutante mit verbesserter chemischer Stabilität
US20060177913A1 (en) 2005-02-08 2006-08-10 Consortium Fur Elektrochemische Industrie Gmbh Process for enantioselective enzymatic reduction of keto compounds
AT501496B1 (de) 2005-02-21 2007-03-15 Iep Gmbh Verfahren zur enantioselektiven enzymatischen reduktion von ketoverbindungen
US20080038803A1 (en) 2005-02-25 2008-02-14 Akira Iwasaki Process for Producing Optically Active Secondary Alcohol
DE102005010804A1 (de) 2005-03-07 2006-09-14 Basf Ag Verfahren zur Herstellung optisch aktiver Alkohole
US7598279B2 (en) * 2005-04-22 2009-10-06 Sk Holdings Co., Ltd. Neurotherapeutic azole compounds
US7393667B2 (en) 2005-05-31 2008-07-01 Bristol-Myers Squibb Company Stereoselective reduction process for the preparation of pyrrolotriazine compounds
AT502395B1 (de) 2005-07-27 2007-03-15 Iep Gmbh Oxidoreduktasen zur stereoselektiven reduktion von ketoverbindungen
JP4745762B2 (ja) 2005-09-02 2011-08-10 住友化学株式会社 還元酵素及びその利用
DE102005044736A1 (de) 2005-09-19 2007-03-22 Basf Ag Neue Dehydrogenasen, deren Derivate und ein Verfahren zur Herstellung von optisch aktiven Alkanolen
AT502185B1 (de) 2005-09-23 2007-02-15 Iep Gmbh Verfahren zur enantioselektiven enzymatischen reduktion von ketoverbindungen
AT503017B1 (de) 2005-12-19 2007-07-15 Iep Gmbh Verfahren zur enantioselektiven enzymatischen reduktion von hydroxyketoverbindungen
WO2007099764A1 (ja) 2006-02-28 2007-09-07 Kaneka Corporation 新規カルボニル還元酵素、その遺伝子、およびそれらを利用した光学活性アルコールの製造方法
WO2007099994A1 (ja) 2006-03-02 2007-09-07 Kaneka Corporation 新規カルボニル還元酵素、その遺伝子、ベクター、形質転換体、およびそれらを利用した光学活性アルコールの製造方法
DE102006010994A1 (de) 2006-03-09 2007-09-13 Wacker Chemie Ag Verfahren zur enzymatischen Herstellung von chiralen Alkoholen
ATE529507T1 (de) 2006-03-31 2011-11-15 Kaneka Corp Verfahren zur produktion von erythro- oder threo- 2-amino-3-hydroxypropionsäureester, neuartige carbonylreduktase, gen für die reduktase, vektor, transformante und verfahren zur produktion von optisch aktivem alkohol unter verwendung dieser
CN101501202A (zh) 2006-06-05 2009-08-05 大赛璐化学工业株式会社 光学活性醇的制造方法
JP4903512B2 (ja) 2006-07-13 2012-03-28 住友化学株式会社 還元酵素遺伝子を含む発現ベクター
WO2008035187A2 (en) 2006-09-21 2008-03-27 Dow Global Technologies Inc. Alcohol dehydrogenase from agromyces sp. and a method of producing a chiral secondary alcohol using same
DE102006055047A1 (de) 2006-11-22 2008-05-29 Wacker Chemie Ag Verfahren zur Herstellung von Dihydroxy-Verbindungen aus Diketo-Verbindungen durch enzymkatalysierte enantioselektive Reduktion
DE102006056526A1 (de) 2006-11-30 2008-06-05 Archimica Gmbh Verfahren zur stereoselektiven Synthese von chiralen Epoxiden durch ADH-Reduktion von alpha-Abgangsgruppen-substituierten Ketonen und Cyclisierung
AT504542B1 (de) 2006-12-07 2008-09-15 Iep Gmbh Verfahren zur enantioselektiven enzymatischen reduktion von secodionderivaten
JP5503534B2 (ja) 2007-06-20 2014-05-28 ビーエーエスエフ ソシエタス・ヨーロピア アゾアルクス（Ａｚｏａｒｃｕｓ）ＳｐＥｂＮ１脱水素酵素を用いる光学活性アルコールの製造方法
TWI601825B (zh) 2007-09-27 2017-10-11 Ｉｅｐ有限公司 對映異構選擇性酶催化還原中間產物之方法
DE102007052112A1 (de) 2007-10-30 2009-05-07 Chiracon Gmbh Pflanzliche Biokatalysatoren zur Herstellung optisch aktiver Hydroxyverbindungen
WO2009070822A2 (en) 2007-12-05 2009-06-11 Angewandte Biokatalyse Kompetenzzentrum Gmbh Recombinant pichia pastoris cell
CN101314787A (zh) 2008-06-24 2008-12-03 江苏华荣生物科技有限公司 用红酵母还原酶制剂制备光学活性手性仲醇的方法
CN101319236A (zh) 2008-07-01 2008-12-10 江南大学 水/离子液体两相体系中生物催化不对称还原羰基化合物的方法
CN101358183B (zh) 2008-09-03 2010-07-14 华东理工大学 红豆羰基还原酶、制备方法和用途

Also Published As

Publication number Publication date
IL216786A (en) 2014-09-30
MX2011013982A (es) 2013-01-29
AU2009348523A1 (en) 2012-01-12
JP2012530513A (ja) 2012-12-06
KR101708433B1 (ko) 2017-02-22
EP2445890B1 (en) 2015-05-06
US20100323410A1 (en) 2010-12-23
US8501436B2 (en) 2013-08-06
MY155662A (en) 2015-11-13
RU2012102051A (ru) 2013-07-27
EP2445890A4 (en) 2012-11-21
RU2508290C2 (ru) 2014-02-27
CA2765566C (en) 2016-04-12
BRPI0924997A2 (pt) 2015-08-11
WO2010150946A1 (en) 2010-12-29
CL2011003244A1 (es) 2012-08-10
EP2445890A1 (en) 2012-05-02
AU2009348523B2 (en) 2015-02-26
BRPI0924997B1 (pt) 2024-01-16
CA2765566A1 (en) 2010-12-29
JP5683580B2 (ja) 2015-03-11
CN102803233A (zh) 2012-11-28
CN102803233B (zh) 2017-03-01
IL216786A0 (en) 2012-02-29
PL2445890T3 (pl) 2016-02-29
KR20100137389A (ko) 2010-12-30
ZA201109362B (en) 2012-08-29

Similar Documents

Publication Publication Date Title
ES2541590T3 (es) Método para la preparación de éster (R)-1-aril-2-tetrazolil-etílico de ácido carbámico
JP2011512870A5 (es)
EP3054016A3 (en) Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
EP3196309A3 (en) Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
MX2009010229A (es) Nuevos microorganismos para la produccion de 1,2-propanodiol obtenido mediante una combinacion de evolucion iy diseño racional.
EP3050972A3 (en) Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
CN104357496B (zh) 一种通过微生物催化乳酸合成己酸的方法
WO2018102070A2 (en) Bioelectrosynthesis of organic compounds
Rafiqul et al. Bioproduction of xylitol by enzyme technology and future prospects
Winn et al. Biofilms and their engineered counterparts: A new generation of immobilised biocatalysts
JP2012205530A (ja) エタノール製造装置およびエタノール製造方法
EA201891956A1 (ru) Способ ферментации с получением лактата магния
HK1103420A1 (en) Compound ws 727713
Tey et al. Current analysis on 1, 3-propanediol production from glycerol via pure wild strain fermentation
CN101955435B (zh) 一种制备酪胺的新方法
JP2011229476A (ja) Ｌ−乳酸の製造方法及び新規微生物
US9447012B2 (en) Synthetic process of adipic acid
CN1043786C (zh) 一种新抗菌化合物的制备方法
WO2009011354A1 (ja) Ｌ－アミノ酸の製造法
US20160362712A1 (en) Method for producing lactones from a strain of aureobasidium pullulans
Loh et al. Conversion of crude glycerol to 1, 3-propanediol by newly isolated Kluyvera cryocrescens
US9328360B2 (en) Conversion of glycerol to 1,3-propanediol under haloalkaline conditions
CN102732579A (zh) 一种微生物转化制备(3s)-3-(叔丁氧羰基)氨基-1-氯-4-苯基-(2r)-丁醇的方法
KR20150069350A (ko) 고수율 1,3-부타디엔의 제조방법
CN106754381B (zh) 一株诱变湛江等鞭金藻及其培养方法